246 related articles for article (PubMed ID: 32645835)
1. Actions of L-thyroxine (T4) and Tetraiodothyroacetic Acid (Tetrac) on Gene Expression in Thyroid Cancer Cells.
Davis PJ; Lin HY; Hercbergs A; Mousa SA
Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32645835
[TBL] [Abstract][Full Text] [Related]
2. Actions of Thyroid Hormones on Thyroid Cancers.
Mousa SA; Hercbergs A; Lin HY; Keating KA; Davis PJ
Front Endocrinol (Lausanne); 2021; 12():691736. PubMed ID: 34234745
[TBL] [Abstract][Full Text] [Related]
3. Cancer Cell Gene Expression Modulated from Plasma Membrane Integrin αvβ3 by Thyroid Hormone and Nanoparticulate Tetrac.
Davis PJ; Glinsky GV; Lin HY; Leith JT; Hercbergs A; Tang HY; Ashur-Fabian O; Incerpi S; Mousa SA
Front Endocrinol (Lausanne); 2014; 5():240. PubMed ID: 25628605
[TBL] [Abstract][Full Text] [Related]
4. Thyroid hormone and anti-apoptosis in tumor cells.
Lin HY; Glinsky GV; Mousa SA; Davis PJ
Oncotarget; 2015 Jun; 6(17):14735-43. PubMed ID: 26041883
[TBL] [Abstract][Full Text] [Related]
5. Nongenomic Actions of Thyroid Hormone: The Integrin Component.
Davis PJ; Mousa SA; Lin HY
Physiol Rev; 2021 Jan; 101(1):319-352. PubMed ID: 32584192
[TBL] [Abstract][Full Text] [Related]
6. Tetrac as an anti-angiogenic agent in cancer.
Schmohl KA; Nelson PJ; Spitzweg C
Endocr Relat Cancer; 2019 Jun; 26(6):R287-R304. PubMed ID: 31063970
[TBL] [Abstract][Full Text] [Related]
7. The combination of tetraiodothyroacetic acid and cetuximab inhibits cell proliferation in colorectal cancers with different K-ras status.
Lee YS; Chin YT; Yang YSH; Wei PL; Wu HC; Shih A; Lu YT; Pedersen JZ; Incerpi S; Liu LF; Lin HY; Davis PJ
Steroids; 2016 Jul; 111():63-70. PubMed ID: 26980146
[TBL] [Abstract][Full Text] [Related]
8. Thyroid hormone induced angiogenesis through the integrin αvβ3/protein kinase D/histone deacetylase 5 signaling pathway.
Liu X; Zheng N; Shi YN; Yuan J; Li L
J Mol Endocrinol; 2014 Jun; 52(3):245-54. PubMed ID: 24532656
[TBL] [Abstract][Full Text] [Related]
9. Tetraiodothyroacetic acid (tetrac) and nanoparticulate tetrac arrest growth of medullary carcinoma of the thyroid.
Yalcin M; Dyskin E; Lansing L; Bharali DJ; Mousa SS; Bridoux A; Hercbergs AH; Lin HY; Davis FB; Glinsky GV; Glinskii A; Ma J; Davis PJ; Mousa SA
J Clin Endocrinol Metab; 2010 Apr; 95(4):1972-80. PubMed ID: 20133461
[TBL] [Abstract][Full Text] [Related]
10. Contributions of Thyroid Hormone to Cancer Metastasis.
Mousa SA; Glinsky GV; Lin HY; Ashur-Fabian O; Hercbergs A; Keating KA; Davis PJ
Biomedicines; 2018 Aug; 6(3):. PubMed ID: 30135398
[TBL] [Abstract][Full Text] [Related]
11. Identification and functions of the plasma membrane receptor for thyroid hormone analogues.
Lin HY; Cody V; Davis FB; Hercbergs AA; Luidens MK; Mousa SA; Davis PJ
Discov Med; 2011 Apr; 11(59):337-47. PubMed ID: 21524387
[TBL] [Abstract][Full Text] [Related]
12. The induction of myeloma cell death and DNA damage by tetrac, a thyroid hormone derivative.
Cohen K; Abadi U; Hercbergs A; Davis PJ; Ellis M; Ashur-Fabian O
Endocr Relat Cancer; 2018 Jan; 25(1):21-34. PubMed ID: 29018054
[TBL] [Abstract][Full Text] [Related]
13. Role of thyroid hormone-integrin αvβ3-signal and therapeutic strategies in colorectal cancers.
Yang YSH; Ko PJ; Pan YS; Lin HY; Whang-Peng J; Davis PJ; Wang K
J Biomed Sci; 2021 Apr; 28(1):24. PubMed ID: 33827580
[TBL] [Abstract][Full Text] [Related]
14. Thyroid hormones differentially regulate phosphorylation of ERK and Akt via integrin αvβ3 receptor in undifferentiated and differentiated PC-12 cells.
Barbakadze T; Natsvlishvili N; Mikeladze D
Cell Biochem Funct; 2014 Apr; 32(3):282-6. PubMed ID: 24214887
[TBL] [Abstract][Full Text] [Related]
15. Integrin αvβ3-Mediated Effects of Thyroid Hormones on Mesenchymal Stem Cells in Tumor Angiogenesis.
Schmohl KA; Mueller AM; Dohmann M; Spellerberg R; Urnauer S; Schwenk N; Ziegler SI; Bartenstein P; Nelson PJ; Spitzweg C
Thyroid; 2019 Dec; 29(12):1843-1857. PubMed ID: 31816265
[No Abstract] [Full Text] [Related]
16.
Godugu K; Mousa SA; Glinsky GV; Lin HY; Davis PJ
Front Endocrinol (Lausanne); 2022; 13():745327. PubMed ID: 35311239
[TBL] [Abstract][Full Text] [Related]
17. Modification of survival pathway gene expression in human breast cancer cells by tetraiodothyroacetic acid (tetrac).
Glinskii AB; Glinsky GV; Lin HY; Tang HY; Sun M; Davis FB; Luidens MK; Mousa SA; Hercbergs AH; Davis PJ
Cell Cycle; 2009 Nov; 8(21):3562-70. PubMed ID: 19838061
[TBL] [Abstract][Full Text] [Related]
18. Membrane receptor for thyroid hormone: physiologic and pharmacologic implications.
Davis PJ; Davis FB; Mousa SA; Luidens MK; Lin HY
Annu Rev Pharmacol Toxicol; 2011; 51():99-115. PubMed ID: 20868274
[TBL] [Abstract][Full Text] [Related]
19. Thyroid hormone inhibition in L6 myoblasts of IGF-I-mediated glucose uptake and proliferation: new roles for integrin αvβ3.
Incerpi S; Hsieh MT; Lin HY; Cheng GY; De Vito P; Fiore AM; Ahmed RG; Salvia R; Candelotti E; Leone S; Luly P; Pedersen JZ; Davis FB; Davis PJ
Am J Physiol Cell Physiol; 2014 Jul; 307(2):C150-61. PubMed ID: 24808494
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of pathological retinal angiogenesis by the integrin αvβ3 antagonist tetraiodothyroacetic acid (tetrac).
Yoshida T; Gong J; Xu Z; Wei Y; Duh EJ
Exp Eye Res; 2012 Jan; 94(1):41-8. PubMed ID: 22123068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]